Mayo clinic tests 'Twinkling' marker to improve breast cancer node detection
NCT ID NCT06999798
Summary
This early-stage study is testing a new type of biopsy marker designed to be easier for surgeons to see on ultrasound scans during breast cancer operations. The marker is placed in a cancerous lymph node before treatment and is meant to help guide surgeons to the correct node for removal months later. Researchers will check if this new 'twinkling' marker is safer and more visible than standard markers in about 20 patients with breast cancer that has spread to lymph nodes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.